Lidocain Braun

Lidocaine, the active ingredient in Lidocain Braun, is a local anesthetic presented as a solution for epidural, intradermal and subcutaneous use. It provides temporary loss of sensation for minor surgical, diagnostic and pain‑management procedures in adult patients. Lidocain Braun is supplied in compliance with European Union pharmaceutical standards and is intended for use by qualified healthcare professionals.

GNH USA supplies Lidocain Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocain Braun, a lidocaine‑based local anesthetic, is used to block nerve conduction in various procedural settings.

- Epidural anesthesia: provides regional pain control during obstetric, orthopedic or abdominal surgeries. - Intradermal injection: numbs the skin for minor dermatologic or diagnostic procedures. - Subcutaneous injection: facilitates local anesthesia for minor surgical interventions such as suturing or biopsy.

Lidocain Braun may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging at the injection site. - Mild dizziness or light‑headedness. - Nausea or mild gastrointestinal discomfort. - Transient swelling or erythema around the injection area. - Temporary numbness extending beyond the intended region. - Mild headache.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with rash, swelling, or difficulty breathing. - Cardiovascular disturbances such as arrhythmia or hypotension. - Central nervous system toxicity presenting as seizures or altered mental status. - Persistent numbness or motor weakness. - Methemoglobinemia leading to cyanosis. - Local tissue necrosis if injected intravascularly.

When using Lidocain Braun, clinicians should observe standard safety measures and patient‑specific considerations.

- Patient assessment: evaluate for known lidocaine allergy or hypersensitivity before administration. - Dose calculation: ensure the total administered dose does not exceed recommended maximum limits for the patient’s weight and age. - Monitoring: observe cardiovascular and neurological status during and after injection. - Injection technique: avoid intravascular injection by aspirating before delivering the solution. - Contraindications: do not use in patients with severe heart block or certain metabolic disorders without specialist advice. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the container.

Lidocain Braun can interact with other medications that affect cardiac conduction or hepatic metabolism.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide) – may potentiate cardiotoxicity. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) – can increase lidocaine plasma levels. - Beta‑blockers – may enhance bradycardic effects.

Moderate Interactions (Monitor Closely): - Other local anesthetics – cumulative toxicity risk. - Diuretics (e.g., furosemide) – may alter plasma protein binding. - Anticonvulsants – potential additive CNS effects. - Calcium channel blockers – may affect cardiac conduction when combined with high lidocaine doses.